Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

251.63 -9.16 (-3.51%)
Official Closing Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
News headline image
Competitor Recall Continues To Show Opportunities For ResMed ↗
 
Via Benzinga
News headline image
Tuesday Is Your Last Chance To Buy ResMed Before The Dividend Payout ↗
  Tuesday marks the last chance for investors to receive the next dividend payout from ResMed (NYSE:RMD). 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗
  
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2022 ↗
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
News headline image
Analyst Ratings for ResMed ↗
Analysts have provided the following ratings for ResMed (NYSE:RMD) within the last quarter: 
Via Benzinga
News headline image
ResMed's Q3 Earnings Short Of Expectations, Profit Margins Contract ↗
 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About ResMed ↗
ResMed (NYSE:RMD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,400 Today ↗
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 11.43% on an annualized basis producing an average annual return of 19.33%. Currently, ResMed has a market capitalization of... 
Via Benzinga
News headline image
How Is The Market Feeling About ResMed? ↗
ResMed's (NYSE:RMD) short percent of float has fallen 6.8% since its last report. The company recently reported that it has 1.39 million shares sold short, which is 0.96% of all... 
Via Benzinga
News headline image
Semiconductor Shortages - See How ResMed Is Tackling ↗
ResMed Inc (NYSE: RMD) has redesigned the AirSense 10 to eliminate a short-supply semiconductor chipset used for cellular communications chips.  
Via Benzinga
News headline image
Here's How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today ↗
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 10.69% on an annualized basis producing an average annual return of 21.91%. Currently, ResMed has a market capitalization of... 
Via Benzinga
News headline image
Peering Into ResMed's Recent Short Interest ↗
ResMed's (NYSE:RMD) short percent of float has risen 14.44% since its last report. The company recently reported that it has 1.50 million shares sold short, which is 1.03% of all... 
Via Benzinga
News headline image
7 Growth Stocks to Buy in July 2022 ↗
The severe macroeconomic climate has led investors toward defensive plays, creating buy opportunities in the following growth stocks. 
Via InvestorPlace
News headline image
Expert Ratings For ResMed ↗
ResMed (NYSE:RMD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Analyzing ResMed's Short Interest ↗
ResMed's (NYSE:RMD) short percent of float has risen 5.62% since its last report. The company recently reported that it has 1.36 million shares sold short, which is 0.94% of all... 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years ↗
ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 9.9% on an annualized basis producing an average annual return of 16.19%. Currently, ResMed has a market capitalization of $29.81... 
Via Benzinga
News headline image
ResMed Strengthens Its Out-Of-Hospital Software Solutions Position With Latest Acquisition - Read How ↗
 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday. 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq tumbled over 300 points in the previous session despite better-than-expected jobs report for May. 
Via Benzinga
News headline image
If You Invested $100 In Resmed 5 Years Ago, Here's How Much You Would Have Today ↗
ResMed (NYSE:RMD) has outperformed the market over the past 5 years by 12.16% on an annualized basis producing an average annual return of 23.39%. Currently, ResMed has a market capitalization of... 
Via Benzinga
News headline image
ResMed Earnings Perspective: Return On Invested Capital ↗
Pulled from Benzinga Pro data, ResMed (NYSE:RMD) posted Q3 earnings of $179.01 million, an increase from Q2 of 11.27%. Sales dropped to $864.50 million, a 3.39% decrease between quarters. 
Via Benzinga
News headline image
What 3 Analyst Ratings Have To Say About ResMed ↗
Over the past 3 months, 3 analysts have published their opinion on ResMed (NYSE:RMD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
News headline image
Earnings Outlook For ResMed ↗
ResMed (NYSE:RMD) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that ResMed will report an... 
Via Benzinga
News headline image
Ten Healthcare Companies With High Payout Ratio ↗
The healthcare industry is among the biggest U.S. market segments in terms of market capitalization, but when it comes to dividend payouts, they rank very low. 
Via Talk Markets
News headline image
3 Top S&P 500 Stock Market Gainers Today: Energy Dominates As Adobe Dives ↗
Energy and commodity plays were top performers Wednesday. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Markets Fall Amid Rising Oil Prices ↗
U.S. indices finished lower Wednesday as investors continue to weigh the Federal Reserve tapering outlook, inflation concerns and the Russia-Ukraine war. Oil prices have also... 
Via Benzinga
News headline image
3 Beaten-Down Growth Stocks With More Than 50% Upside Potential ↗
The key to picking growth stocks right now is to look for companies whose earnings momentum and growth can withstand any market conditions. 
Via InvestorPlace
News headline image
Ominous Death Cross Forms On ResMed's Chart ↗
If history is any guide, there may be trouble ahead for shares of ResMed (NYSE:RMD). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
News headline image
ResMed's Return on Invested Capital Overview ↗
According to Benzinga Pro, during Q2, ResMed (NYSE:RMD) earned $201.75 million, a 0.91% increase from the preceding quarter. ResMed's sales decreased to $894.87 million, a 1.01%... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.